KRH 594

Drug Profile

KRH 594

Alternative Names: WK 1492; WK 14922K

Latest Information Update: 16 May 2000

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wakunaga Pharmaceutical
  • Developer Kissei Pharmaceutical; Wakunaga Pharmaceutical
  • Class Antihypertensives; Small molecules
  • Mechanism of Action Angiotensin type 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetic nephropathies; Heart failure; Hypertension

Most Recent Events

  • 16 May 2000 KRH 594 is available for licensing worldwide (
  • 16 May 2000 Discontinued-II for Hypertension in Japan (PO)
  • 16 May 2000 Discontinued-Preclinical for Diabetic nephropathies in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top